ClinicalTrials.Veeva

Menu

Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.

N

National University of Malaysia

Status

Completed

Conditions

Maternal
Cord
Vaccine
Antibody

Study type

Observational

Funder types

Other

Identifiers

NCT05305261
FF-2021-362

Details and patient eligibility

About

This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.

Full description

Covid -19 infection has been a significant public health burden as it shifted the paradigm of infectious diseases aiming to control the spread and enhance public immune protection. The introduction of Covid -19 vaccination in December 2020 aimed to combat the infection, thus tremendously helping to flatten the disease worldwide. Channeling the vaccine for the obstetrics field is one of the hallmark strategies to reduce maternal morbidity and mortality. The efficacy of vaccination for the pregnant lady has been established. However, fetus protection via transmission of the antibody during pregnancy is still uncertain. Therefore, this study aims to consolidate further evidence of transplacental antibody post-maternal vaccination aiming for fetal protection following delivery.

Enrollment

197 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • term pregnancies at 37 weeks or more
  • vaccinated 2 doses
  • in labour

Exclusion criteria

  • unvaccinated
  • preterm labour less than 37 weeks
  • multiple pregnancies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems